PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.02%
Revenue growth of 5.02% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
1.81%
Gross profit growth of 1.81% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
2.13%
EBIT growth of 2.13% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
6.86%
Operating income growth of 6.86% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
1.99%
Net income growth of 1.99% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
2.00%
EPS growth 50-75% of Healthcare median of 2.70%. Guy Spier might worry about subpar cost control or limited growth levers.
2.00%
Diluted EPS growth 75-90% of Healthcare median of 2.47%. John Neff would press for more efficient cost or share repurchases.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.95%
10Y CAGR of 70.95% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
66.15%
5Y CAGR of 66.15% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
36.76%
3Y CAGR of 36.76% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
100.00%
OCF/share CAGR of 100.00% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
212.66%
Net income/share CAGR exceeding 1.5x Healthcare median of 28.45% over a decade. Joel Greenblatt might see a standout compounder of earnings.
73.93%
5Y net income/share CAGR > 1.5x Healthcare median of 21.05%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
37.10%
3Y net income/share CAGR > 1.5x Healthcare median of 13.70%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
219.61%
Equity/share CAGR of 219.61% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
131.65%
5Y equity/share CAGR of 131.65% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
64.76%
3Y equity/share CAGR of 64.76% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.71%
AR growth of 77.71% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
1.23%
Inventory growth of 1.23% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
2.13%
Asset growth of 2.13% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
2.84%
BV/share growth of 2.84% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
57.98%
Debt growth of 57.98% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
0.69%
SG&A growth of 0.69% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.